Close X
Wednesday, November 13, 2024
ADVT 
Health

'Off switch' for pain discovered

Darpan News Desk IANS, 30 Nov, 2014 01:48 PM
    Researchers have uncovered a new way to block neuropathic pain including pain caused by chemotherapeutic agents and bone cancer.
     
    Turning on a receptor called A3 in the brain and spinal cord could quell pain, the results of the research found.
     
    The receptor can be activated by its chemical stimulator, the small molecule adenosine.
     
    "It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain," said researcher Daniela Salvemini from the Saint Louis University in the US.
     
    "Our findings suggest that this goal may be achieved by focusing future work on the A3AR (adenosine receptor) pathway as its activation provides robust pain reduction across several types of pain," Salvemini added.
     
    The most successful pharmacological approaches for the treatment of chronic pain rely on certain pathways: circuits involving opioid, adrenergic and calcium channels.
     
    For the past decade, scientists have tried to take advantage of these known pathways where the series of interactions between molecular-level components take place that consequently lead to pain.
     
    While adenosine had shown potential for pain-killing in humans, researchers had not successfully leveraged this particular pain pathway because the targeted receptor engaged many side effects.
     
    In this research on animal models, Salvemini and colleagues demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
     
    The study appeared in the journal Brain.

    MORE Health ARTICLES

    Tiny needles hold promise for two key eye diseases

    Tiny needles hold promise for two key eye diseases
    Needles too tiny to be seen with naked eyes can soon deliver drugs to specific areas relevant to two of the world's leading eye diseases - glaucoma and corneal....

    Tiny needles hold promise for two key eye diseases

    New Alzheimer's-related memory disorder found

    New Alzheimer's-related memory disorder found
    Alzheimer's disease now has a new cousin as an international team of researchers has determined criteria for a new neurological disorder called....

    New Alzheimer's-related memory disorder found

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers
    TORONTO — A clinical trial of the made-in-Canada Ebola vaccine will be conducted in this country, Health Canada and the Public Health Agency of Canada announced Friday.

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers

    Sloppy Contact Lens Use Is Driving More 1 Million Eye Infections Each Year

    Sloppy Contact Lens Use Is Driving More 1 Million Eye Infections Each Year
    NEW YORK — A new government report says sloppy care of contact lenses is a main reason for hundreds of thousands of eye infections each year.

    Sloppy Contact Lens Use Is Driving More 1 Million Eye Infections Each Year

    Phone use may lead to brain cancer

    Phone use may lead to brain cancer
    The longer someone talks over the phone - in terms of hours and years - the more likely is he/she to develop glioma, a deadly form of brain cancer, says a new study....

    Phone use may lead to brain cancer

    Artificial retina could help restore vision of elderly

    Artificial retina could help restore vision of elderly
    A team of researchers has created a wireless and light-sensitive, flexible film that could potentially substitute a damaged retina....

    Artificial retina could help restore vision of elderly